ID   CALM1_MOUSE             Reviewed;         149 AA.
AC   P0DP26; P02593; P62204; P70667; P99014; Q3TEH7; Q3THK5; Q3U6Z5; Q3U7C7;
AC   Q498A3; Q61379; Q61380; Q8BNC9; Q91VQ9; Q9D6G4;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2017, sequence version 1.
DT   18-JUN-2025, entry version 56.
DE   RecName: Full=Calmodulin-1 {ECO:0000250|UniProtKB:P0DP23};
GN   Name=Calm1 {ECO:0000312|MGI:MGI:88251}; Synonyms=Calm, Cam, Cam1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3384819; DOI=10.1016/s0021-9258(19)81579-x;
RA   Bender P.K., Dedman J.R., Emerson C.P. Jr.;
RT   "The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-
RT   deficient skeletal muscle.";
RL   J. Biol. Chem. 263:9733-9737(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=12106288; DOI=10.1111/j.1460-9568.1990.tb00460.x;
RA   Kato K.;
RT   "A collection of cDNA clones with specific expression patterns in mouse
RT   brain.";
RL   Eur. J. Neurosci. 2:704-711(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, DBA/2J, and NOD;
RC   TISSUE=Amnion, Bone marrow, Colon, Hippocampus, Kidney, Liver, Lung,
RC   Mammary gland, Ovary, Placenta, Stomach, Testis, Thymus, and Tongue;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=129, C57BL/6J, and Czech II;
RC   TISSUE=Brain, Mammary tumor, Placenta, and Spinal ganglion;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-14, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J; TISSUE=Liver;
RA   Bienvenut W.V.;
RL   Submitted (JUL-2005) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 15-31; 79-87 AND 92-107, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=C57BL/6J; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Kang S.U.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [7]
RP   INTERACTION WITH ITPR1.
RX   PubMed=10620513; DOI=10.1042/bj3450357;
RA   Adkins C.E., Morris S.A., De Smedt H., Sienaert I., Toeroek K.,
RA   Taylor C.W.;
RT   "Ca2+-calmodulin inhibits Ca2+ release mediated by type-1, -2 and -3
RT   inositol trisphosphate receptors.";
RL   Biochem. J. 345:357-363(2000).
RN   [8]
RP   INTERACTION WITH GIMAP4.
RX   PubMed=16569770; DOI=10.1182/blood-2005-11-4616;
RA   Schnell S., Demolliere C., van den Berk P., Jacobs H.;
RT   "Gimap4 accelerates T-cell death.";
RL   Blood 108:591-599(2006).
RN   [9]
RP   INTERACTION WITH RYR1 AND RYR2.
RX   PubMed=18650434; DOI=10.1074/jbc.m804432200;
RA   Wright N.T., Prosser B.L., Varney K.M., Zimmer D.B., Schneider M.F.,
RA   Weber D.J.;
RT   "S100A1 and calmodulin compete for the same binding site on ryanodine
RT   receptor.";
RL   J. Biol. Chem. 283:26676-26683(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=18034455; DOI=10.1021/pr0701254;
RA   Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
RT   "Large-scale identification and evolution indexing of tyrosine
RT   phosphorylation sites from murine brain.";
RL   J. Proteome Res. 7:311-318(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100 AND SER-102, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-22, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [13]
RP   INTERACTION WITH IQCF1.
RX   PubMed=25380116; DOI=10.1111/andr.296;
RA   Fang P., Xu W., Li D., Zhao X., Dai J., Wang Z., Yan X., Qin M., Zhang Y.,
RA   Xu C., Wang L., Qiao Z.;
RT   "A novel acrosomal protein, IQCF1, involved in sperm capacitation and the
RT   acrosome reaction.";
RL   Andrology 3:332-344(2015).
RN   [14]
RP   INTERACTION WITH SYT7.
RX   PubMed=24569478; DOI=10.7554/elife.01524;
RA   Liu H., Bai H., Hui E., Yang L., Evans C.S., Wang Z., Kwon S.E.,
RA   Chapman E.R.;
RT   "Synaptotagmin 7 functions as a Ca2+-sensor for synaptic vesicle
RT   replenishment.";
RL   Elife 3:E01524-E01524(2014).
RN   [15]
RP   INTERACTION WITH HINT1 AND HINT3.
RX   PubMed=31088288; DOI=10.1089/ars.2019.7724;
RA   Cortes-Montero E., Rodriguez-Munoz M., Sanchez-Blazquez P., Garzon J.;
RT   "The Axonal Motor Neuropathy-Related HINT1 Protein Is a Zinc- and
RT   Calmodulin-Regulated Cysteine SUMO Protease.";
RL   Antioxid. Redox Signal. 31:503-520(2019).
RN   [16]
RP   INTERACTION WITH GARIN2, AND SUBCELLULAR LOCATION.
RX   PubMed=29025071; DOI=10.1093/humrep/dex290;
RA   Ma Q., Li Y., Luo M., Guo H., Lin S., Chen J., Du Y., Jiang Z., Gui Y.;
RT   "The expression characteristics of FAM71D and its association with sperm
RT   motility.";
RL   Hum. Reprod. 32:2178-2187(2017).
RN   [17]
RP   INTERACTION WITH IQUB.
RX   PubMed=36417862; DOI=10.1016/j.celrep.2022.111683;
RA   Zhang X., Xiao Z., Zhang J., Xu C., Liu S., Cheng L., Zhou S., Zhao S.,
RA   Zhang Y., Wu J., Wang Y., Liu M.;
RT   "Differential requirements of IQUB for the assembly of radial spoke 1 and
RT   the motility of mouse cilia and flagella.";
RL   Cell Rep. 41:111683-111683(2022).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 3-147 IN COMPLEX WITH MYO5A.
RX   PubMed=17151196; DOI=10.1073/pnas.0609436103;
RA   Houdusse A., Gaucher J.F., Krementsova E., Mui S., Trybus K.M., Cohen C.;
RT   "Crystal structure of apo-calmodulin bound to the first two IQ motifs of
RT   myosin V reveals essential recognition features.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:19326-19331(2006).
RN   [19] {ECO:0007744|PDB:3WFN}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 1893-1914 IN COMPLEX WITH SCN8A,
RP   INTERACTION WITH SCN8A, AND MUTAGENESIS OF GLU-115; GLU-121; GLU-124 AND
RP   GLU-128.
RX   PubMed=23942337; DOI=10.1038/srep02435;
RA   Reddy Chichili V.P., Xiao Y., Seetharaman J., Cummins T.R., Sivaraman J.;
RT   "Structural basis for the modulation of the neuronal voltage-gated sodium
RT   channel NaV1.6 by calmodulin.";
RL   Sci. Rep. 3:2435-2435(2013).
CC   -!- FUNCTION: Calmodulin acts as part of a calcium signal transduction
CC       pathway by mediating the control of a large number of enzymes, ion
CC       channels, aquaporins and other proteins through calcium-binding.
CC       Calcium-binding is required for the activation of calmodulin. Among the
CC       enzymes to be stimulated by the calmodulin-calcium complex are a number
CC       of protein kinases, such as myosin light-chain kinases and calmodulin-
CC       dependent protein kinase type II (CaMK2), and phosphatases. Together
CC       with CCP110 and centrin, is involved in a genetic pathway that
CC       regulates the centrosome cycle and progression through cytokinesis. Is
CC       a regulator of voltage-dependent L-type calcium channels. Mediates
CC       calcium-dependent inactivation of CACNA1C. Positively regulates
CC       calcium-activated potassium channel activity of KCNN2. Forms a
CC       potassium channel complex with KCNQ1 and regulates electrophysiological
CC       activity of the channel via calcium-binding. Acts as a sensor to
CC       modulate the endoplasmic reticulum contacts with other organelles
CC       mediated by VMP1:ATP2A2. {ECO:0000250|UniProtKB:P0DP23}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts with CEP97, CCP110,
CC       MYO1C, TTN/titin and SRY. Interacts with MYO10. Interacts with RRAD (By
CC       similarity). Interacts with USP6; the interaction is calcium dependent
CC       (By similarity). Interacts with CDK5RAP2. Interacts with SCN5A (By
CC       similarity). Interacts with FCHO1. Interacts with MIP in a 1:2
CC       stoichiometry; the interaction with the cytoplasmic domains from two
CC       MIP subunits promotes MIP water channel closure. Interacts with ORAI1;
CC       this may play a role in the regulation of ORAI1-mediated calcium
CC       transport (By similarity). Interacts with RYR1 (PubMed:18650434).
CC       Interacts with MYO5A (PubMed:17151196). Interacts with IQCF1
CC       (PubMed:25380116). Interacts with SYT7 (PubMed:24569478). Interacts
CC       with CEACAM1 (via cytoplasmic domain); this interaction is in a calcium
CC       dependent manner and reduces homophilic cell adhesion through
CC       dissociation of dimer (By similarity). Interacts with RYR2; regulates
CC       RYR2 calcium-release channel activity (PubMed:18650434). Interacts with
CC       PCP4; regulates calmodulin calcium-binding (By similarity). Interacts
CC       with the heterotetrameric KCNQ2 and KCNQ3 channel; the interaction is
CC       calcium-independent, constitutive and participates in the proper
CC       assembly of a functional heterotetrameric M channel (By similarity).
CC       Interacts with alpha-synuclein/SNCA (By similarity). Interacts with
CC       SLC9A1 in a calcium-dependent manner (By similarity). In the absence of
CC       Ca(+2), interacts with GIMAP4 (via IQ domain) (PubMed:16569770).
CC       Interacts with SCN8A; the interaction modulates the inactivation rate
CC       of SCN8A (PubMed:23942337). Interaction with KIF1A; the interaction is
CC       increased in presence of calcium and increases neuronal dense core
CC       vesicles motility (By similarity). Interacts with KCNN3 (By
CC       similarity). Interacts with KCNQ1 (via C-terminus); forms a
CC       heterooctameric structure (with 4:4 KCNQ1:CALM stoichiometry) in a
CC       calcium-independent manner (By similarity). Interacts with PIK3C3; the
CC       interaction modulates PIK3C3 kinase activity (By similarity). Interacts
CC       with HINT1; interaction increases in the presence of calcium ions
CC       (PubMed:31088288). Interacts with HINT3 (PubMed:31088288). Interacts
CC       with GARIN2; in mature sperm flagella (PubMed:29025071). Interacts with
CC       IQUB (PubMed:36417862). Interacts with SLC26A5 (via STAS domain); this
CC       interaction is calcium-dependent and the STAS domain interacts with
CC       only one lobe of CALM1 which is an elongated conformation (By
CC       similarity). Ca(2+)-bound CALM1 binds CNGA1:CNGB1 channel (via CaM1 and
CC       CaM2 regions); this interaction modulates the affinity of the channel
CC       for cNMPs in response to intracellular Ca(2+) levels. Interacts with
CC       ITPR1; this interaction inhibits inositol 1,4,5 trisphosphate binding
CC       in both the presence and absence of calcium and 1,4,5 trisphosphate-
CC       induced calcium release in the presence of calcium (PubMed:10620513).
CC       Component of the SIFI complex (By similarity). Interacts with KCNN4;
CC       this interaction allows channel opening (By similarity). Interacts with
CC       KCNN2; this interaction regulates the channel activity through calcium-
CC       binding (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P0DP23,
CC       ECO:0000250|UniProtKB:P0DP29, ECO:0000250|UniProtKB:P62161,
CC       ECO:0000269|PubMed:10620513, ECO:0000269|PubMed:16569770,
CC       ECO:0000269|PubMed:17151196, ECO:0000269|PubMed:18650434,
CC       ECO:0000269|PubMed:23942337, ECO:0000269|PubMed:24569478,
CC       ECO:0000269|PubMed:25380116, ECO:0000269|PubMed:29025071,
CC       ECO:0000269|PubMed:31088288, ECO:0000269|PubMed:36417862}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:P0DP23}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000250|UniProtKB:P0DP23}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:P0DP23}. Cell
CC       projection, cilium, flagellum {ECO:0000269|PubMed:29025071}.
CC       Note=Distributed throughout the cell during interphase, but during
CC       mitosis becomes dramatically localized to the spindle poles and the
CC       spindle microtubules. {ECO:0000250|UniProtKB:P0DP23}.
CC   -!- DOMAIN: The N-terminal and C-terminal lobes of CALM bind to the C-
CC       terminus of KCNQ1 in a clamp-like conformation. Binding of CALM C-
CC       terminus to KCNQ1 is calcium-independent but is essential for assembly
CC       of the structure. Binding of CALM N-terminus to KCNQ1 is calcium-
CC       dependent and regulates electrophysiological activity of the channel
CC       (By similarity). The C-lobe interacts with KCNN4 channels in a calcium-
CC       independent manner, whereas the N-lobe interacts with the S4-S5 linker
CC       of KCNN4 in a calcium-dependent manner playing a role as calcium sensor
CC       and gating the channel (By similarity). {ECO:0000250|UniProtKB:P0DP23}.
CC   -!- PTM: Ubiquitination results in a strongly decreased activity.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation results in a decreased activity. {ECO:0000250}.
CC   -!- MISCELLANEOUS: This protein has four functional calcium-binding sites.
CC       {ECO:0000250|UniProtKB:P0DP23}.
CC   -!- SIMILARITY: Belongs to the calmodulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M19381; AAA66182.1; -; mRNA.
DR   EMBL; X61432; CAA43674.1; -; mRNA.
DR   EMBL; AK004673; BAB23462.1; -; mRNA.
DR   EMBL; AK013695; BAB28959.1; -; mRNA.
DR   EMBL; AK088141; BAC40168.1; -; mRNA.
DR   EMBL; AK150288; BAE29443.1; -; mRNA.
DR   EMBL; AK150978; BAE30007.1; -; mRNA.
DR   EMBL; AK151001; BAE30025.1; -; mRNA.
DR   EMBL; AK151552; BAE30497.1; -; mRNA.
DR   EMBL; AK151784; BAE30686.1; -; mRNA.
DR   EMBL; AK151923; BAE30801.1; -; mRNA.
DR   EMBL; AK151992; BAE30856.1; -; mRNA.
DR   EMBL; AK152148; BAE30984.1; -; mRNA.
DR   EMBL; AK152715; BAE31439.1; -; mRNA.
DR   EMBL; AK152719; BAE31442.1; -; mRNA.
DR   EMBL; AK152850; BAE31543.1; -; mRNA.
DR   EMBL; AK152897; BAE31579.1; -; mRNA.
DR   EMBL; AK153004; BAE31644.1; -; mRNA.
DR   EMBL; AK153348; BAE31924.1; -; mRNA.
DR   EMBL; AK153426; BAE31985.1; -; mRNA.
DR   EMBL; AK153546; BAE32083.1; -; mRNA.
DR   EMBL; AK159762; BAE35353.1; -; mRNA.
DR   EMBL; AK160057; BAE35595.1; -; mRNA.
DR   EMBL; AK160508; BAE35832.1; -; mRNA.
DR   EMBL; AK161302; BAE36309.1; -; mRNA.
DR   EMBL; AK162314; BAE36849.1; -; mRNA.
DR   EMBL; AK166308; BAE38695.1; -; mRNA.
DR   EMBL; AK167353; BAE39452.1; -; mRNA.
DR   EMBL; AK168002; BAE39990.1; -; mRNA.
DR   EMBL; AK168241; BAE40191.1; -; mRNA.
DR   EMBL; AK168663; BAE40516.1; -; mRNA.
DR   EMBL; AK168803; BAE40633.1; -; mRNA.
DR   EMBL; AK169027; BAE40819.1; -; mRNA.
DR   EMBL; AK169055; BAE40843.1; -; mRNA.
DR   EMBL; AK169640; BAE41271.1; -; mRNA.
DR   EMBL; BC054805; AAH54805.1; -; mRNA.
DR   CCDS; CCDS36523.1; -.
DR   PIR; I49567; I49567.
DR   RefSeq; NP_001300863.1; NM_001313934.1.
DR   RefSeq; NP_033920.1; NM_009790.5.
DR   PDB; 1UP5; X-ray; 1.90 A; A/B=2-149.
DR   PDB; 2DFS; EM; 24.00 A; B/C/D/E/F/G/N/O/P/Q/R/S=2-149.
DR   PDB; 2IX7; X-ray; 2.50 A; A/B=3-147.
DR   PDB; 3WFN; X-ray; 1.95 A; B/C/D/E=1-149.
DR   PDB; 4E50; X-ray; 2.70 A; A=1-149.
DR   PDB; 4E53; X-ray; 2.69 A; A/B=1-149.
DR   PDB; 4HEX; X-ray; 2.00 A; A/B=1-149.
DR   PDB; 4ZLK; X-ray; 2.50 A; B=1-149.
DR   PDB; 7B1G; EM; 3.60 A; E=1-149.
DR   PDB; 7CQP; X-ray; 1.90 A; B=1-78.
DR   PDB; 7YV9; EM; 4.78 A; B/C/D/E/F/G/I/J/K/L/M/N=1-149.
DR   PDB; 8OF8; EM; 7.50 A; A/B/C/D/E/F=2-149.
DR   PDB; 8W41; EM; 3.54 A; B/I=1-149.
DR   PDB; 9CFU; EM; 2.80 A; R=1-148.
DR   PDB; 9CFV; EM; 2.70 A; R=1-148.
DR   PDB; 9CFW; EM; 3.00 A; R=1-148.
DR   PDB; 9CFX; EM; 2.70 A; R=1-148.
DR   PDBsum; 1UP5; -.
DR   PDBsum; 2DFS; -.
DR   PDBsum; 2IX7; -.
DR   PDBsum; 3WFN; -.
DR   PDBsum; 4E50; -.
DR   PDBsum; 4E53; -.
DR   PDBsum; 4HEX; -.
DR   PDBsum; 4ZLK; -.
DR   PDBsum; 7B1G; -.
DR   PDBsum; 7CQP; -.
DR   PDBsum; 7YV9; -.
DR   PDBsum; 8OF8; -.
DR   PDBsum; 8W41; -.
DR   PDBsum; 9CFU; -.
DR   PDBsum; 9CFV; -.
DR   PDBsum; 9CFW; -.
DR   PDBsum; 9CFX; -.
DR   AlphaFoldDB; P0DP26; -.
DR   EMDB; EMD-11985; -.
DR   EMDB; EMD-16850; -.
DR   EMDB; EMD-34121; -.
DR   EMDB; EMD-37260; -.
DR   EMDB; EMD-45563; -.
DR   EMDB; EMD-45564; -.
DR   EMDB; EMD-45565; -.
DR   EMDB; EMD-45566; -.
DR   SMR; P0DP26; -.
DR   FunCoup; P0DP26; 4417.
DR   STRING; 10090.ENSMUSP00000019514; -.
DR   ChEMBL; CHEMBL3562176; -.
DR   GlyGen; P0DP26; 1 site, 1 N-linked glycan (1 site).
DR   iPTMnet; P0DP26; -.
DR   MetOSite; P0DP26; -.
DR   PhosphoSitePlus; P0DP26; -.
DR   SwissPalm; P0DP26; -.
DR   jPOST; P0DP26; -.
DR   PaxDb; 10090-ENSMUSP00000019514; -.
DR   Pumba; P0DP26; -.
DR   Antibodypedia; 39411; 192 antibodies from 17 providers.
DR   Antibodypedia; 4344; 514 antibodies from 34 providers.
DR   Antibodypedia; 53945; 71 antibodies from 14 providers.
DR   DNASU; 12313; -.
DR   Ensembl; ENSMUST00000019514.10; ENSMUSP00000019514.10; ENSMUSG00000019370.11.
DR   Ensembl; ENSMUST00000040440.7; ENSMUSP00000048857.7; ENSMUSG00000036438.15.
DR   Ensembl; ENSMUST00000110082.11; ENSMUSP00000105709.4; ENSMUSG00000001175.17.
DR   GeneID; 12313; -.
DR   KEGG; mmu:12313; -.
DR   KEGG; mmu:12314; -.
DR   KEGG; mmu:12315; -.
DR   AGR; MGI:88251; -.
DR   CTD; 801; -.
DR   CTD; 805; -.
DR   CTD; 808; -.
DR   MGI; MGI:88251; Calm1.
DR   VEuPathDB; HostDB:ENSMUSG00000001175; -.
DR   VEuPathDB; HostDB:ENSMUSG00000019370; -.
DR   VEuPathDB; HostDB:ENSMUSG00000036438; -.
DR   eggNOG; KOG0027; Eukaryota.
DR   InParanoid; P0DP26; -.
DR   OMA; ARKMKEC; -.
DR   OrthoDB; 9559602at2759; -.
DR   Reactome; R-MMU-111932; CaMK IV-mediated phosphorylation of CREB.
DR   Reactome; R-MMU-111933; Calmodulin induced events.
DR   Reactome; R-MMU-111957; Cam-PDE 1 activation.
DR   Reactome; R-MMU-114608; Platelet degranulation.
DR   Reactome; R-MMU-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-MMU-163615; PKA activation.
DR   Reactome; R-MMU-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-MMU-2025928; Calcineurin activates NFAT.
DR   Reactome; R-MMU-203615; eNOS activation.
DR   Reactome; R-MMU-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   Reactome; R-MMU-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-MMU-4086398; Ca2+ pathway.
DR   Reactome; R-MMU-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-MMU-425561; Sodium/Calcium exchangers.
DR   Reactome; R-MMU-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-MMU-442729; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde.
DR   Reactome; R-MMU-445355; Smooth Muscle Contraction.
DR   Reactome; R-MMU-451308; Activation of Ca-permeable Kainate Receptor.
DR   Reactome; R-MMU-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-MMU-5578775; Ion homeostasis.
DR   Reactome; R-MMU-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   Reactome; R-MMU-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-MMU-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-MMU-5673000; RAF activation.
DR   Reactome; R-MMU-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-MMU-70221; Glycogen breakdown (glycogenolysis).
DR   Reactome; R-MMU-8876725; Protein methylation.
DR   Reactome; R-MMU-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-MMU-936837; Ion transport by P-type ATPases.
DR   Reactome; R-MMU-9619229; Activation of RAC1 downstream of NMDARs.
DR   Reactome; R-MMU-9648002; RAS processing.
DR   Reactome; R-MMU-9856530; High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells.
DR   BioGRID-ORCS; 12313; 7 hits in 81 CRISPR screens.
DR   BioGRID-ORCS; 12314; 4 hits in 74 CRISPR screens.
DR   BioGRID-ORCS; 12315; 1 hit in 77 CRISPR screens.
DR   ChiTaRS; Calm1; mouse.
DR   EvolutionaryTrace; P0DP26; -.
DR   PRO; PR:P0DP26; -.
DR   Proteomes; UP000000589; Chromosome 12.
DR   Proteomes; UP000000589; Chromosome 17.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; P0DP26; protein.
DR   Bgee; ENSMUSG00000001175; Expressed in ureter smooth muscle and 283 other cell types or tissues.
DR   ExpressionAtlas; P0DP26; baseline and differential.
DR   GO; GO:0034704; C:calcium channel complex; IEA:Ensembl.
DR   GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR   GO; GO:1902494; C:catalytic complex; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IDA:CAFA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0099524; C:postsynaptic cytosol; IEA:Ensembl.
DR   GO; GO:0099523; C:presynaptic cytosol; IEA:Ensembl.
DR   GO; GO:0030017; C:sarcomere; IEA:Ensembl.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl.
DR   GO; GO:0097225; C:sperm midpiece; IDA:UniProtKB.
DR   GO; GO:0005876; C:spindle microtubule; IEA:Ensembl.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IEA:Ensembl.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IGI:MGI.
DR   GO; GO:0010856; F:adenylate cyclase activator activity; IEA:Ensembl.
DR   GO; GO:0008179; F:adenylate cyclase binding; IEA:Ensembl.
DR   GO; GO:0019855; F:calcium channel inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IEA:Ensembl.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IEA:Ensembl.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IEA:Ensembl.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0072542; F:protein phosphatase activator activity; IEA:Ensembl.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; IEA:Ensembl.
DR   GO; GO:0031432; F:titin binding; IEA:Ensembl.
DR   GO; GO:0044325; F:transmembrane transporter binding; IEA:Ensembl.
DR   GO; GO:0031800; F:type 3 metabotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0016240; P:autophagosome membrane docking; ISS:UniProtKB.
DR   GO; GO:0097720; P:calcineurin-mediated signaling; IEA:Ensembl.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IEA:Ensembl.
DR   GO; GO:0071346; P:cellular response to type II interferon; IEA:Ensembl.
DR   GO; GO:0005513; P:detection of calcium ion; IEA:Ensembl.
DR   GO; GO:0090151; P:establishment of protein localization to mitochondrial membrane; IEA:Ensembl.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:MGI.
DR   GO; GO:1990456; P:mitochondrion-endoplasmic reticulum membrane tethering; ISS:UniProtKB.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0140056; P:organelle localization by membrane tethering; ISS:UniProtKB.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; IEA:Ensembl.
DR   GO; GO:0140238; P:presynaptic endocytosis; IDA:SynGO.
DR   GO; GO:0098901; P:regulation of cardiac muscle cell action potential; IEA:Ensembl.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:0032465; P:regulation of cytokinesis; IEA:Ensembl.
DR   GO; GO:0002027; P:regulation of heart rate; IEA:Ensembl.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; IEA:Ensembl.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IEA:Ensembl.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0051412; P:response to corticosterone; IEA:Ensembl.
DR   CDD; cd00051; EFh; 2.
DR   FunFam; 1.10.238.10:FF:000527; Calmodulin-3; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 3.
DR   InterPro; IPR050230; CALM/Myosin/TropC-like.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR23048:SF0; CALMODULIN LIKE 3; 1.
DR   PANTHER; PTHR23048; MYOSIN LIGHT CHAIN 1, 3; 1.
DR   Pfam; PF13499; EF-hand_7; 2.
DR   PRINTS; PR00450; RECOVERIN.
DR   SMART; SM00054; EFh; 4.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Cell projection; Cilium; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Flagellum; Isopeptide bond;
KW   Metal-binding; Methylation; Phosphoprotein; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.5"
FT   CHAIN           2..149
FT                   /note="Calmodulin-1"
FT                   /id="PRO_0000439935"
FT   DOMAIN          8..43
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          44..79
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          81..116
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          117..149
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          77..149
FT                   /note="Necessary and sufficient for interaction with PCP4"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   BINDING         21
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         23
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         25
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         27
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         32
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         57
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         59
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         61
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         63
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         94
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         96
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         98
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         100
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         105
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         130
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         132
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         134
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         136
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   BINDING         141
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448,
FT                   ECO:0007744|PDB:4HEX, ECO:0007744|PDB:4ZLK"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.5"
FT   MOD_RES         22
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         45
FT                   /note="Phosphothreonine; by CaMK4"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP29"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         95
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         100
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18034455,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         111
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         116
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         116
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         139
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62157"
FT   MUTAGEN         115
FT                   /note="E->A: Decreases interaction with SCN8A in the
FT                   absence of calcium."
FT                   /evidence="ECO:0000269|PubMed:23942337"
FT   MUTAGEN         121
FT                   /note="E->A: Decreases interaction with SCN8A in the
FT                   absence of calcium."
FT                   /evidence="ECO:0000269|PubMed:23942337"
FT   MUTAGEN         124
FT                   /note="E->A: Decreases interaction with SCN8A in the
FT                   absence of calcium."
FT                   /evidence="ECO:0000269|PubMed:23942337"
FT   MUTAGEN         128
FT                   /note="E->A: Decreases interaction with SCN8A in the
FT                   absence of calcium."
FT                   /evidence="ECO:0000269|PubMed:23942337"
FT   CONFLICT        26
FT                   /note="G -> N (in Ref. 1; AAA66182)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        55
FT                   /note="E -> V (in Ref. 3; BAE41271)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="F -> L (in Ref. 3; BAE40191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        82
FT                   /note="S -> G (in Ref. 3; BAE31439/BAE31644/BAE31442)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126
FT                   /note="I -> T (in Ref. 3; BAE31579)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="V -> L (in Ref. 3; BAB28959)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..4
FT                   /evidence="ECO:0007829|PDB:3WFN"
FT   HELIX           7..20
FT                   /evidence="ECO:0007829|PDB:7CQP"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:7CQP"
FT   HELIX           30..39
FT                   /evidence="ECO:0007829|PDB:7CQP"
FT   HELIX           46..56
FT                   /evidence="ECO:0007829|PDB:7CQP"
FT   STRAND          61..65
FT                   /evidence="ECO:0007829|PDB:7CQP"
FT   HELIX           66..77
FT                   /evidence="ECO:0007829|PDB:7CQP"
FT   HELIX           78..93
FT                   /evidence="ECO:0007829|PDB:4HEX"
FT   STRAND          98..102
FT                   /evidence="ECO:0007829|PDB:3WFN"
FT   HELIX           103..112
FT                   /evidence="ECO:0007829|PDB:3WFN"
FT   STRAND          113..115
FT                   /evidence="ECO:0007829|PDB:3WFN"
FT   HELIX           119..128
FT                   /evidence="ECO:0007829|PDB:3WFN"
FT   STRAND          131..133
FT                   /evidence="ECO:0007829|PDB:4E53"
FT   STRAND          136..138
FT                   /evidence="ECO:0007829|PDB:3WFN"
FT   HELIX           139..146
FT                   /evidence="ECO:0007829|PDB:3WFN"
SQ   SEQUENCE   149 AA;  16838 MW;  6B4BC3FCDE10727B CRC64;
     MADQLTEEQI AEFKEAFSLF DKDGDGTITT KELGTVMRSL GQNPTEAELQ DMINEVDADG
     NGTIDFPEFL TMMARKMKDT DSEEEIREAF RVFDKDGNGY ISAAELRHVM TNLGEKLTDE
     EVDEMIREAD IDGDGQVNYE EFVQMMTAK
//
